These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17260013)

  • 1. SPARC enhances tumor stroma formation and prevents fibroblast activation.
    Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
    Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
    Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
    Hasselaar P; Sage EH
    J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer.
    Wu MP; Young MJ; Tzeng CC; Tzeng CR; Huang KF; Wu LW; Chou CY
    Carcinogenesis; 2008 Jun; 29(6):1115-23. PubMed ID: 18413367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
    Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
    Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
    Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
    Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
    Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
    Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
    J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
    Kato Y; Tsukuda M; Nagashima Y; Koshika S; Sakai N; Yao M; Kubota Y; Aoki I; Colledge WH; Foidart JM; Hata R; Thompson EW
    Int J Oncol; 2005 Sep; 27(3):759-68. PubMed ID: 16077926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.
    Clark CJ; Sage EH
    J Cell Biochem; 2008 Jun; 104(3):721-32. PubMed ID: 18253934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor-mediated interaction between tumor cells and stromal fibroblasts in an experimental model of human small-cell lung cancer.
    Sugimoto T; Takiguchi Y; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Hiroshima K; Minamihisamatsu M; Miyamoto T; Kuriyama T
    Oncol Rep; 2005 Oct; 14(4):823-30. PubMed ID: 16142338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
    Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
    Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in human periodontal ligament cells.
    Fujita T; Shiba H; Van Dyke TE; Kurihara H
    Cell Biol Int; 2004; 28(4):281-6. PubMed ID: 15109984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
    Puolakkainen PA; Brekken RA; Muneer S; Sage EH
    Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of the ovarian cancer microenvironment by SPARC.
    Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
    Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
    Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
    Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.